Cardiology Archives - Page 4 of 6

Clinical and economic burden of out-of-hospital cardiac arrest in US commercial insurance population (2014 to 2019)

Authors: V Chirikov, S Corman, Y Qiao, X Huang Published: American Journal of Cardiology, 2022 View publication Abstract Little is known about the economic burden incurred by out-of-hospital cardiac arrest (OHCA) in...

Cost effectiveness of Vericiguat for the treatment of chronic heart failure with reduced ejection fraction following a worsening heart failure event from a US Medicare perspective

Authors: A Alsumali, L M Djatche, A Briggs, R Liu, I Diakite, D Patel, Y Wang, D Lautsch Published: PharmacoEconomics, 2021 View publication Objective Given the high economic burden of disease among...

Lipid management across Europe in the real-world setting: a rapid evidence review

Authors: V Barrios, J Soronen, A M Carter, A Anastassopoulou Published: Current Medical Research and Opinion, 2021 View publication Objectives To provide a contemporary overview of recent real-world lipid-lowering therapy (LLT) practices...

Clinical implications and cost-effectiveness analysis of Rivaroxaban in patients with coronary artery disease or peripheral arterial disease in the Netherlands

Authors: J A Spoorendonk, J-B Briere, K Bowrin, A Millier, M Coppens, S Tempelaar, B Verheggen Published: Journal of Medical Economics, 2021 View publication Background Patients with stable coronary artery disease (CAD)...

Introduction of a novel service model to improve uptake and adherence with cardiac rehabilitation within Buckinghamshire Healthcare NHS Trust

Authors: F McCartan, N Bowers, J Turner, M Mandalia, N Kalnad, A Bishop-Bailey, J Fu, P Clifford Published: BMC cardiovascular disorders, 2017 View publication Background Buckinghamshire Healthcare NHS Trust (BHT) carried out...

Diagnosis, management and prognosis of familial hypercholesterolaemia in a UK tertiary cardiac centre

Authors: M Barbir, J Breen, E Neves, L Priestley-Barnham, F Lazem & R Grocott-Mason Published: 2019 View publication Abstract Objective: To describe demographic characteristics, current local clinical management and outcomes for patients...

A retrospective observational study to determine baseline characteristics and early prescribing patterns for patients receiving Alirocumab in UK clinical practice

Authors: T Reynolds, J George, G Konidaris, D Narayanan, S Ramachandran, L Saunders, A Viljoen, G Ferns Published: 2019 View publication Background Alirocumab is a fully human monoclonal antibody to proprotein convertase...

Current perspectives on the attainment of lipid modification goals relating to the use of statins and Ezetimibe for the prevention of cardiovascular disease in the United Kingdom

Authors: T M Reynolds, A Pottle, S H Quoraishi Published: Journal of Endocrine Society, 2021 View publication Abstract Despite widespread evidence of the effectiveness of lipid modification for the reduction of cardiovascular...

Budget impact analysis of vericiguat for the treatment of chronic heart failure with reduced ejection fraction following a worsening event

Authors: A Alsumali, D Lautsch, R Liu, D Patel, S Nanji, L M Djatche Published: Advances in Therapy, 2021 View publication Introduction In the USA, patients with chronic heart failure (HF) with...

News